CitroTech (NYSEAMERICAN:CITR) used its first-quarter 2026 earnings call to frame the company’s transition from technology ...
Automotive OEM Collaboration -- Delivered initial waveguide-based smart glasses for operational evaluation by a leading auto ...
SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it ...
Operating Cash Use -- $3.8 million consumed in operating activities during the quarter. Provision for Credit Losses -- ...
IRB Approval Secured for PF614-MPAR-102 Part 3 ~~ Clinical Peer-Reviewed Data Published for First Overdose Protected Opioid PF614-MPAR®; Patent Estate Expanded ~~ Company Launches Formal Review of ...
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company leveraging its proprietary RADR ® artificial intelligence (AI) and machine learning (ML) platform to transform ...
Stroboscopic light therapy started in the lab, detoured through wellness culture, and arrived somewhere genuinely interesting ...
MarketBeat on MSN
Vuzix Q1 Earnings Call Highlights
3 Penny Stocks Ready to Break Out in 2025 Vuzix (NASDAQ:VUZI) reported a smaller first-quarter loss as operating expenses declined, while revenue fell year over year amid lower product sales, ...
Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three months ...
New data from IM1240 (capped-CD3 × 5T4 × NKG2A) tri-specific antibody demonstrated potent anti-tumor activity across all treatment-resistant patient-derived tumor samples Established CAPTN-3 ...
Designing a series of sweetener trials seemed straightforward enough to us as behavioural scientists who specialise in human ...
A detailed review of Rules for the Summer by Meghan Quinn — a funny, emotional, and banter-filled small-town romance packed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results